Latest Updates of Key Players in the Laboratory Animal Medicine Market
Company Profile
| Company | Headquarters | Latest Update |
| Zoetis Services LLC | Netherlands | In November 2025, Zoetis Inc. announced the acquisition of Veterinary Pathology Group (VPG). The acquisition further expands Zoetis’ comprehensive diagnostics portfolio and reinforces its commitment to improving animal health through innovative, advanced-quality diagnostic services. |
| Boehringer Ingelheim International GmbH | Germany | Boehringer Ingelheim Animal Health USA Inc. is the lead sponsor of the symposium organized by the American Association of Veterinary Medical Colleges. |
| Merck & Co., Inc. | Germany | In May 2025, Merck and imec announced a strategic collaboration to develop an advanced microphysiological systems (MPS) stand. |
| Dechra | United Kingdom | In November 2025, Dechra became a Human-Animal Bond Certified organization, committing to helping related research and education. |
| Elanco Animal Health | United States | With evolving diseases and shifting agricultural demands, Elanco endures to invest in digital transformation, R&D, and worldwide partnerships |
| Kent Scientific Corporation | United States | Kent Scientific recently provided the Dermus SkinScanner in the U.S. and Canada for non-invasive, data-driven skin analysis in preclinical settings. |
Value Chain Analysis
R&D
- Research and Development (R&D) in laboratory animal medicine includes a systematic technology of scientific investigation to advance animal health, enhance diagnostic abilities, and develop novel treatments.
- Key Players: American College of Laboratory Animal Medicine (ACLAM) and AALAS
Manufacturing Processes
- Manufacturing processes in laboratory animal medicine include an integration of extremely regulated pharmaceutical production for animal health products and specialized technology for the care, maintenance, and experimental operation of research animals.
- Key Players: ICLAS (International Council for Laboratory Animal Science)
Patient Services
- Patient services in laboratory animal medicine refer to the inclusive veterinary medical care, health surveillance, and support provided to animals used in biomedical studies, testing, and awareness.
- Key Players: ILAR (Institute for Laboratory Animal Research)
Market Growth
The laboratory animal medicine market is on an upward trajectory, poised to generate substantial revenue growth, potentially climbing into the hundreds of millions over the forecast years from 2026 to 2035. This surge is attributed to evolving consumer preferences and technological advancements reshaping the industry.
Recent Developments in the Laboratory Animal Medicine Market
- In November 2025, Zoetis Inc. announced the acquisition of Veterinary Pathology Group (VPG), a foremost veterinary diagnostic laboratory group with multiple locations in Ireland and the UK. The acquisition also expands Zoetis’ comprehensive diagnostics selection and reinforces its commitment to progressing animal health via innovative and high-quality diagnostic solutions.
- In June 2025, Novartis announced that it completed its acquisition of Regulus Therapeutics Inc. By the completion of the acquisition, shares of common stock, par value $0.001 per share, of Regulus ceased trading on the Nasdaq Stock Market LLC, and Regulus is nowadays an indirect, exclusively owned subsidiary of Novartis
All your Laboratory Animal Medicine Market insights, streamlined and simplified - Access the Dashboard
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking
